PAVmed issues 1.5M shares to Sunrise Labs for $750k development payment

PAVmed Inc.

1,500,000 common shares issued to Sunrise Labs as $750k advance for Veris Health monitor electronics.
Six-month lookback: if VWAP value < $750k, PAVmed pays cash or additional shares capped at 9.99% outstanding.
Shares issued in unregistered sale under Section 4(a)(2); Sunrise is accredited investor.
Transaction preserves cash while funding implantable monitor for cancer patients.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.